Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine

Limited data exist concerning the long-term (≥5 year) survival rates of patients with stage IIIB and IV non-small cell lung carcinoma (NSCLC) receiving chemotherapy. We aimed to determine the long-term results of cisplatin plus third-generation (vinorelbine or gemcitabine) cytotoxic chemotherapy in...

Descripción completa

Detalles Bibliográficos
Autores principales: OZKAYA, SEVKET, FINDIK, SERHAT, DIRICAN, ADEM, ATICI, ATILLA GÜVEN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494120/
https://www.ncbi.nlm.nih.gov/pubmed/23226770
http://dx.doi.org/10.3892/etm.2012.714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494120/
https://www.ncbi.nlm.nih.gov/pubmed/23226770
http://dx.doi.org/10.3892/etm.2012.714

Ejemplares similares